John Murphy employed the phrase “force multiply” or a derivative multiple times when describing how to improve the generic drug industry’s advocacy on Capitol Hill.
Key Takeaways
-
John A. Murphy III, former chief policy officer at BIO, will become the president and CEO of the Association for Accessible Medicines.
-
Murphy said in an interview that he wants to increase and amplify the voices advocating for the generic industry
The new president and CEO of the Association for Accessible Medicines, the generic industry’s primary trade association, understands the message that generics save billions of dollars annually is not new, as are the problems currently plaguing it,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?